These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 2778256

  • 1. Control of nephrotoxicity in the rat during repeated cis-platinum treatments.
    Jones MM, Basinger MA.
    J Appl Toxicol; 1989 Aug; 9(4):229-33. PubMed ID: 2778256
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of cis-diamminedichloroplatinum (II)--induced renal toxicity in the rat.
    Jones MM, Basinger MA, Mitchell WM, Bradley CA.
    Cancer Chemother Pharmacol; 1986 Aug; 17(1):38-42. PubMed ID: 3698175
    [Abstract] [Full Text] [Related]

  • 3. Dithiocarbamate-induced biliary platinum excretion and the control of cis-platinum nephrotoxicity.
    Basinger MA, Jones MM, Gilbreath SG, Walker EM, Fody EP, Mayhue MA.
    Toxicol Appl Pharmacol; 1989 Feb; 97(2):279-88. PubMed ID: 2538006
    [Abstract] [Full Text] [Related]

  • 4. Cisplatin-induced loss of kidney copper and nephrotoxicity is ameliorated by single dose diethyldithiocarbamate, but not mesna.
    DeWoskin RS, Riviere JE.
    Toxicol Appl Pharmacol; 1992 Feb; 112(2):182-9. PubMed ID: 1311464
    [Abstract] [Full Text] [Related]

  • 5. Control of some aspects of cis-platinum nephrotoxicity.
    Jones MM, Basinger MA, Craft WD, Domingo JL, Llobet JM.
    Arch Toxicol; 1986 Oct; 59(3):167-71. PubMed ID: 3028320
    [Abstract] [Full Text] [Related]

  • 6. Magnesium co-administration decreases cisplatin-induced nephrotoxicity in the multiple cisplatin administration.
    Saito Y, Okamoto K, Kobayashi M, Narumi K, Furugen A, Yamada T, Iseki K.
    Life Sci; 2017 Nov 15; 189():18-22. PubMed ID: 28864226
    [Abstract] [Full Text] [Related]

  • 7. The prevention of cisplatin-induced renal dysfunction by hydroxyl-containing dithiocarbamates.
    Reznik LV, Myazina EM, Shakchmatova EI, Gambaryan SP, Brovtsyn VK, Natochin YV, Jones MM.
    Br J Cancer; 1991 Feb 15; 63(2):234-6. PubMed ID: 1847647
    [Abstract] [Full Text] [Related]

  • 8. Comparative effects of diethyldithiocarbamate and N-benzyl-D-glucamine dithiocarbamate on cis-diamminedichloroplatinum-induced toxicity in kidney and gastrointestinal tract in rats.
    Hidaka S, Funakoshi T, Shimada H, Tsuruoka M, Kojima S.
    J Appl Toxicol; 1995 Feb 15; 15(4):267-73. PubMed ID: 7594195
    [Abstract] [Full Text] [Related]

  • 9. The effects of 2,3-dimercapto-1-propanesulfonic acid (DMPS) and meso-2,3-dimercaptosuccinic acid (DMSA) on the nephrotoxicity in the mouse during repeated cisplatin (CDDP) treatments.
    Yajima Y, Kawaguchi M, Yoshikawa M, Okubo M, Tsukagoshi E, Sato K, Katakura A.
    J Pharmacol Sci; 2017 Jun 15; 134(2):108-115. PubMed ID: 28648300
    [Abstract] [Full Text] [Related]

  • 10. Effects of sodium thiosulfate on the pharmacokinetics of unchanged cisplatin and on the distribution of platinum species in rat kidney: protective mechanism against cisplatin nephrotoxicity.
    Nagai N, Hotta K, Yamamura H, Ogata H.
    Cancer Chemother Pharmacol; 1995 Jun 15; 36(5):404-10. PubMed ID: 7634382
    [Abstract] [Full Text] [Related]

  • 11. Effects of a cisplatin-chondroitin sulfate A complex in reducing the nephrotoxicity of cisplatin.
    Zhang JS, Imai T, Otagiri M.
    Arch Toxicol; 2000 Aug 15; 74(6):300-7. PubMed ID: 11005675
    [Abstract] [Full Text] [Related]

  • 12. The effect of heavy metal chelators on the renal accumulation of platinum after cis-dichlorodiammineplatinum II administration to the rat.
    Graziano J, Jones B, Pisciotto P.
    Br J Pharmacol; 1981 Jul 15; 73(3):649-54. PubMed ID: 6265016
    [Abstract] [Full Text] [Related]

  • 13. Nephrotoxicity of cisplatin, carboplatin and transplatin. A comparative in vitro study.
    Hannemann J, Baumann K.
    Arch Toxicol; 1990 Jul 15; 64(5):393-400. PubMed ID: 2169720
    [Abstract] [Full Text] [Related]

  • 14. Relative effectiveness of some compounds for the control of cisplatin-induced nephrotoxicity.
    Jones MM, Basinger MA, Holscher MA.
    Toxicology; 1991 Jul 15; 68(3):227-47. PubMed ID: 1896997
    [Abstract] [Full Text] [Related]

  • 15. Effects of the diuretics mannitol or acetazolamide on nephrotoxicity and physiological disposition of cisplatin in rats.
    Osman NM, Copley MP, Litterst CL.
    Cancer Chemother Pharmacol; 1984 Jul 15; 13(1):58-62. PubMed ID: 6428763
    [Abstract] [Full Text] [Related]

  • 16. Effects of disopyramide and verapamil on renal disposition and nephrotoxicity of cisplatin in rats.
    Hanada K, Odaka K, Kudo A, Ogata H.
    Pharm Res; 1999 Oct 15; 16(10):1589-95. PubMed ID: 10554102
    [Abstract] [Full Text] [Related]

  • 17. [Measurement of creatinine clearance and urinary NAG for the evaluation of cis-platinum induced nephrotoxicity].
    Kubota A, Yoshida T, Tsukuda M, Furukawa S, Miyata K, Mochimatsu I, Sawaki S.
    Gan To Kagaku Ryoho; 1989 Aug 15; 16(8 Pt 1):2599-605. PubMed ID: 2774590
    [Abstract] [Full Text] [Related]

  • 18. Studies on nephrotoxicity following a single and repeated administration of cis-diamminedichloroplatinum (CDDP) in rats.
    Mizushima Y, Nagahama H, Yokoyama A, Morikage T, Yano S.
    Tohoku J Exp Med; 1987 Feb 15; 151(2):129-35. PubMed ID: 3576612
    [Abstract] [Full Text] [Related]

  • 19. Protective effect of N-benzyl-D-glucamine dithiocarbamate against renal toxicity in rats during repeated cis-diamminedichloroplatinum administrations.
    Hidaka S, Funakoshi T, Shimada H, Tsuruoka M, Kojima S.
    Ren Fail; 1995 Sep 15; 17(5):539-50. PubMed ID: 8570866
    [Abstract] [Full Text] [Related]

  • 20. Protective effects of dithiocarbamates against renal toxicity of cis-diamminedichloroplatinum in rats.
    Hidaka S, Tsuruoka M, Funakoshi T, Shimada H, Kiyozumi M, Kojima S.
    Ren Fail; 1994 Sep 15; 16(3):337-49. PubMed ID: 8059017
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.